Lexaria Bioscience Corp. — Director's Dealing 2015

Nov 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-30	Common Shares	P	7000	$0.1839	Acquired	5987206	Direct
2015-10-30	Common Shares	P	1500	$0.179	Acquired	5988706	Direct
2015-11-02	Common Shares	P	5000	$0.184	Acquired	5993706	Direct
2015-11-02	Common Shares	P	1500	$0.24	Acquired	5995206	Direct
2015-11-02	Common Shares	P	10000	$0.25	Acquired	6005206	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5980206	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect

Footnotes

F1: Purchase price was in Canadian Dollars

F2: Purchase price was in Canadian Dollars